Engineered Recombinant Proteins for Precise Gene Integration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current gene therapy methods for treating genetic defects lack efficiency, specificity, accuracy, and fidelity in integrating therapeutic genes into the host genome.

Innovation Solution

Development of engineered proteins comprising retroelement-derived polypeptides fused with heterologous polypeptides, such as RNA/DNA processing, repair, binding, or nucleosome binding domains, to enhance integration characteristics.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If traditional gene therapy vectors are used for delivering therapeutic genes, then gene delivery can be achieved, but integration efficiency, specificity, accuracy, and fidelity into the host genome are insufficient

Engineering Contradiction:
Improveintegration efficiencyVSAvoidintegration accuracy
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent creates composite proteins by fusing retroelement-derived polypeptides with heterologous polypeptides containing RNA/DNA processing, repair, binding, or nucleosome binding domains. This composite structure combines the genome integration capability of retroelements with the precision and control functions of heterologous domains, thereby simultaneously improving integration efficiency and accuracy

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The invention merges multiple functional domains into a single engineered protein: the retroelement-derived polypeptide provides integration efficiency while heterologous domains contribute RNA/DNA processing, repair, and binding functions. This merging allows the system to achieve both high productivity in integration and high manufacturing precision in terms of integration accuracy and fidelity

Inventive Principle:
Principle #5Merging (Combining)

2Reliability

If retroelement-derived polypeptides are used alone, then integration function is provided, but integration specificity and fidelity are insufficient

Engineering Contradiction:
Improveintegration fidelityVSAvoidprotein structure complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The engineered protein is segmented into distinct functional modules: the retroelement-derived polypeptide segment handles integration, while separate heterologous domain segments handle RNA/DNA processing, repair, and binding. This segmentation allows each domain to perform its specialized function optimally, improving integration fidelity without creating an uncontrollably complex structure

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The heterologous polypeptide domains provide multiple functions simultaneously: RNA processing, DNA repair, nucleic acid binding, and nucleosome interaction. This multi-functionality within added domains improves integration reliability and fidelity without requiring proportionally increased structural complexity, as each heterologous domain is a self-contained functional unit

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS20260022357A1Recombinant proteins for gene delivery and insertion
Publication Date: 2026.01.22 AVERNA THERAPEUTICS LTD
  • US20260022357A1 patent drawing
  • US20260022357A1 patent drawing
  • US20260022357A1 patent drawing

AI summary

The present disclosure provides compositions and methods for delivering a gene of interest to a subject. Aspects of the application relate to nucleic acids encoding modified retroelement-derived polypeptides and gene delivery constructs that can direct integration of a nucleic acid sequence into a target nucleic acid (e.g., a genome of a subject).